Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.
Matsuda T, Miyauchi E, Hsu YW, Nagayama S, Kiyotani K, Zewde M, Park JH, Kato T, Harada M, Matsui S, Ueno M, Fukuda K, Suzuki N, Hazama S, Nagano H, Takeuchi H, Vigneswaran WT, Kitagawa Y, Nakamura Y. Matsuda T, et al. Among authors: miyauchi e. Oncoimmunology. 2019 Mar 22;8(6):e1588085. doi: 10.1080/2162402X.2019.1588085. eCollection 2019. Oncoimmunology. 2019. PMID: 31069156 Free PMC article.
Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).
Miyauchi E, Inoue A, Kobayashi K, Maemondo M, Sugawara S, Oizumi S, Isobe H, Gemma A, Saijo Y, Yoshizawa H, Hagiwara K, Nukiwa T; North-East Japan Study Group. Miyauchi E, et al. Jpn J Clin Oncol. 2015 Jul;45(7):670-6. doi: 10.1093/jjco/hyv054. Epub 2015 Apr 15. Jpn J Clin Oncol. 2015. PMID: 25877748 Clinical Trial.
Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.
Yamane Y, Shiono A, Ishii Y, Isobe K, Miyauchi E, Kishi K, Nishino M, Sugawara S, Ko R, Koyama N, Yabuki Y, Kobayashi K. Yamane Y, et al. Among authors: miyauchi e. Jpn J Clin Oncol. 2016 Dec;46(12):1135-1142. doi: 10.1093/jjco/hyw124. Epub 2016 Sep 21. Jpn J Clin Oncol. 2016. PMID: 27655904
CD45+CD326+ Cells are Predictive of Poor Prognosis in Non-Small Cell Lung Cancer Patients.
Ishizawa K, Yamanaka M, Saiki Y, Miyauchi E, Fukushige S, Akaishi T, Asao A, Mimori T, Saito R, Tojo Y, Yamashita R, Abe M, Sakurada A, Pham NA, Li M, Okada Y, Ishii T, Ishii N, Kobayashi S, Nagasaki M, Ichinose M, Tsao MS, Horii A. Ishizawa K, et al. Among authors: miyauchi e. Clin Cancer Res. 2019 Nov 15;25(22):6756-6763. doi: 10.1158/1078-0432.CCR-19-0545. Epub 2019 Aug 5. Clin Cancer Res. 2019. PMID: 31383733
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02).
Tanaka H, Sakamoto H, Akita T, Ohyanagi F, Kawashima Y, Tambo Y, Tanimoto A, Horiike A, Miyauchi E, Tsuchiya-Kawano Y, Yanagitani N, Nishio M. Tanaka H, et al. Among authors: miyauchi e. Thorac Cancer. 2022 May;13(10):1471-1478. doi: 10.1111/1759-7714.14415. Epub 2022 Apr 12. Thorac Cancer. 2022. PMID: 35415873 Free PMC article.
A phase II study of S-1 in relapsed small cell lung cancer.
Kudo K, Ohyanagi F, Horiike A, Miyauchi E, Tahanaka H, Yanagitani N, Saito R, Kaburaki K, Sakatani T, Horai T, Nishio M. Kudo K, et al. Among authors: miyauchi e. Mol Clin Oncol. 2013 Mar;1(2):263-266. doi: 10.3892/mco.2013.67. Epub 2013 Jan 14. Mol Clin Oncol. 2013. PMID: 24649158 Free PMC article.
128 results